Name
GS1-10 - Primary Results From the Randomized Phase Il RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2- Advanced Breast Cancer Treated With Ribociclib + Endocrine Therapy vs Physician's Choice Combination Chemotherapy
Date & Time
Tuesday, December 6, 2022
Speakers
Virtual Session Link